Indefinite Delivery Contract 75N91023D00005
Award Date
3/27/23
Last Date to Order
3/26/27
Federal Agency
National Cancer Institute
Awardee
Regimed Medical
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to Alchem Laboratories Corporation. The contract has a potential value of $7,777,665 and a period of performance from September 2017 to September 2022.
Under the contract, Alchem Laboratories Corporation provides non-good manufacturing practices synthesis of small molecules to support the National Cancer Institute's...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts.
The contract was awarded in...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types.
The initial $120,500 task order under this contract requires the...
The National Institutes of Health National Cancer Institute awarded an indefinite delivery/indefinite quantity multiple award contract to provide support services for cancer clinical trials. Under the master contract, Technical Resources International was issued delivery orders valued at $5.56 million to provide project kickoff meeting support and centralized protocol writing support. Performance will take place in Westlake, Maryland through July 2027.
The original solicitation sought to...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $550,000 single-award contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract and aims to procure tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program.
Under a $488,000 delivery order, Sloan-Kettering Institute for Cancer Research,...
The National Institutes of Health National Cancer Institute awarded a single-award indefinite delivery/indefinite quantity contract to ASE Direct, Inc. to procure erlotinib hydrochloride tablets in support of cancer research efforts. The contract has a potential value of $6.6M over a three-year ordering period ending January 2023. ASE Direct will supply 25mg, 100mg, and 150mg tablet formulations of the cancer drug under firm fixed price delivery orders, with performance at its facility in...
This single-award IDV was issued by the National Cancer Institute, part of the Department of Health and Human Services, on April 11, 2023 with a potential value of $12.1 million. The contract aims to procure analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations to support the Institute's research efforts. Research Triangle Institute was selected as the prime contractor to deliver the required products and services over a five-year ordering period ending April...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $178,230 firm fixed-price delivery order is for the recovery and delivery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the agency's efforts to characterize the genomic changes in cancer....
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation.
The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07....
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to the non-profit organization Health Research, Inc. (HRI). The contract, valued at $765,306, supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various cancer types for genomic characterization.
Under the contract, HRI's Roswell Park Division, doing business...